GENETHON

AcronymDefinition
GENETHONHuman Genome Research Centre (French)
References in periodicals archive ?
* Researchers at Whitehead and Genethon publish a physical map of the human genome containing 15,000 markers.
"ECL has enabled Genethon to push human genome mapping to 1.
"We chose ECL for its straightforward protocols and clear results," commented Daniel Cohen, head of Genethon, as he described his breakthrough results of completing the physical map of all 23 chromosomes that make up the human genome.
"Because Genethon was set up as a nonradioactive laboratory, it was possible for us to facilitate the application of ECL in collaboration with the researchers," says John Maynard, Amersham's research director.
FRENCH RSVP...Human genome researchers worldwide are singing the praises of the multimillion dollar Genethon facilities which house the latest in robotic and gene-mapping technology.
Prior to joining Audentes, Mavilio served as scientific director of Genethon, Evry, France (2012-2017).
[USPRwire, Thu Apr 09 2015] Global Markets Direct's, 'Genethon - Product Pipeline Review - 2015', provides an overview of the Genethon's pharmaceutical research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Genethon's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
[ClickPress, Mon Aug 11 2014] Global Markets Direct's, 'Genethon - Product Pipeline Review - 2014', provides an overview of the Genethon's pharmaceutical research and development focus.
Most recently Dr Masquelier served as general manager of Genethon, president of GenoSafe, president of Aster-Cephac and general manager of Southern Europe for MDS Pharma Services.
Some of the leading companies active in this enterprising development are Alnylam Pharmaceuticals Inc, Amarna Therapeutics BV, Bayer AG, Bioverativ Inc, Catalyst Biosciences Inc, China Biologic Products Inc, CSL Ltd, Dimension Therapeutics Inc, Genethon SA and Green Cross Corp.
- Dr Didier Caizergues, Head of regulatory Affairs Department, International Regulatory Affairs department, GENETHON